Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes
Abstract Background The diabetogenic effect of statins has been well established by clinical trials, Mendelian randomisation studies and meta-analyses. According to large clinical trials, PCSK9 inhibitors (PCSK9i) have no deleterious impact on glucose metabolism. However, few real-life studies have...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2024-01-01
|
| Collection: | Cardiovascular Diabetology |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12933-023-02077-y |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|